Search - tctmd.com

Displaying 801 - 820 of 900

Sort: Relevancy | Date

Presentation ESC 2012

Personalized antiplatelet treatment after percutaneous coronary intervention: The MADONNA study

Presenter: 159942|Jolanta Siller-Matula

August 26, 2012

Presentation

Initial and Chronic Response to Clopidogrel After Stenting for ACS and Influence on Clinical Outcomes

Presenter: Thomas Cuisset

August 17, 2012

Presentation ACVS 2012

Which Antiplatelets to Use for PCI?

Presenter: Dev Pahlajani

August 04, 2012

Presentation ACVS 2012

Peri-Operative Medical Management of Patient with Recurrent Ischemia

Presenter: Ravi Kumar Aluri

August 03, 2012

Presentation ACVS 2012

Bivalirudin Versus Heparin in STEMI

Presenter: Colonel Anil Dhall

August 03, 2012

Presentation

Prior Smoking Status, Clinical Outcomes, and the Comparison of Ticagrelor with Clopidogrel in ACS

Presenter: Jan H. Cornel

August 02, 2012

Presentation

Pantoprazole Significantly Interferes with Antiplatelet Effect of Clopidogrel

Presenter: Maria Serena Parri

July 31, 2012

Presentation

Clopidogrel Discontinuation After Myocardial Infarction and Risk of Thrombosis

Presenter: Mette Charlot

July 19, 2012

Presentation

Cilostazol Added to Aspirin and Clopidogrel Reduces Revascularization Without Increases in Major Adverse Events in Patients With DES

Presenter: Ryota Sakurai

July 12, 2012

Presentation

Efficacy and Safety of Intensified Antiplatelet Therapy Based on Reactivity Testing After PCI

Presenter: D?niel Aradi

July 11, 2012

Presentation

Cost-Effectiveness of Apixaban vs. Aspirin for Stroke Prevention Among A-fib Pts Unsuitable for Warfarin

Presenter: S. Lee

July 11, 2012

Presentation

Comparison of Abciximab vs. Eptifibatide During PCI in STEMI (from the HORIZONS-AMI Trial)

Presenter: H. S. Singh

July 05, 2012

Presentation

Cost-Effectiveness of Treating ACS Patients with Ticagrelor for 12 Months

Presenter: Elisabet Nikolic

June 25, 2012

Presentation

TRA2P TIMI-50 Subanalysis: Vorapaxar for Secondary Prevention in PAD Patients

Presenter: 204599|MP Bonaca

June 22, 2012

Presentation

Periprocedural Bleeding and Thromboembolic Events with Dabigatran Compared to Warfarin

Presenter: Jeff S. Healey

June 21, 2012

Presentation

Recovery of Platelet Function After Discontinuation of Prasugrel or Clopidogrel in Stable CAD Patients

Presenter: Matthew J. Price

June 13, 2012

Presentation

Prolonged Clopidogrel Use After BMS and DES Placement: The VA Drug-Eluting Stent Study

Presenter: David P. Faxon

June 08, 2012

Presentation

Prognostic Value of High On-Clopidogrel Platelet Reactivity in Bivalirudin- vs. Abciximab-Treated NSTEMI Patients

Presenter: Dirk Sibbing

June 06, 2012

Presentation

Clinical Impact of Intracoronary Abciximab in Patients Undergoing Primary PCI

Presenter: R. Piccolo

June 04, 2012

Presentation

Duration of DAPT and Long-term Clinical Outcome After Coronary DES Implantation

Presenter: T. Tada

June 01, 2012

Advertisement

Personalized antiplatelet treatment after percutaneous coronary intervention: The MADONNA study

Initial and Chronic Response to Clopidogrel After Stenting for ACS and Influence on Clinical Outcomes

Which Antiplatelets to Use for PCI?

Peri-Operative Medical Management of Patient with Recurrent Ischemia

Bivalirudin Versus Heparin in STEMI

Prior Smoking Status, Clinical Outcomes, and the Comparison of Ticagrelor with Clopidogrel in ACS

Pantoprazole Significantly Interferes with Antiplatelet Effect of Clopidogrel

Clopidogrel Discontinuation After Myocardial Infarction and Risk of Thrombosis

Cilostazol Added to Aspirin and Clopidogrel Reduces Revascularization Without Increases in Major Adverse Events in Patients With DES

Efficacy and Safety of Intensified Antiplatelet Therapy Based on Reactivity Testing After PCI

Cost-Effectiveness of Apixaban vs. Aspirin for Stroke Prevention Among A-fib Pts Unsuitable for Warfarin

Comparison of Abciximab vs. Eptifibatide During PCI in STEMI (from the HORIZONS-AMI Trial)

Cost-Effectiveness of Treating ACS Patients with Ticagrelor for 12 Months

TRA2P TIMI-50 Subanalysis: Vorapaxar for Secondary Prevention in PAD Patients

Periprocedural Bleeding and Thromboembolic Events with Dabigatran Compared to Warfarin

Recovery of Platelet Function After Discontinuation of Prasugrel or Clopidogrel in Stable CAD Patients

Prolonged Clopidogrel Use After BMS and DES Placement: The VA Drug-Eluting Stent Study

Prognostic Value of High On-Clopidogrel Platelet Reactivity in Bivalirudin- vs. Abciximab-Treated NSTEMI Patients

Clinical Impact of Intracoronary Abciximab in Patients Undergoing Primary PCI

Duration of DAPT and Long-term Clinical Outcome After Coronary DES Implantation

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content